ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 092,11
-0,61%
Dow Jones
39 671,04
-0,51%
DAX
18 680,20
-0,25%
Brent Oil
81,375
-0,19%
Bitcoin
69 318,39
0,31%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Allergy Therapeutics Plc (AGY)

  7. Allergy Therapeutics Plc (AGY) Actualités

AGY

Allergy Therapeutics (AGY)

Allergy Therapeutics Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:AGY
DateHeureSourceTitreSymboleSociété
07/05/202421h22Alliance NewsAlliance NewsTRADING UPDATES: Abingdon Health buys IVDeology HoldingsLSE:AGYAllergy Therapeutics Plc
07/05/202408h00RNS Regulatory NewsAllergy Therapeutics PLC Further detail from G306 Phase III field trialLSE:AGYAllergy Therapeutics Plc
03/04/202408h00RNS Regulatory NewsAllergy Therapeutics PLC Director ResignationLSE:AGYAllergy Therapeutics Plc
27/03/202417h13Alliance NewsAlliance NewsEARNINGS AND TRADING: Solid State ups outlook; Quartix trading in lineLSE:AGYAllergy Therapeutics Plc
27/03/202408h00RNS Regulatory NewsAllergy Therapeutics PLC Interim Results for six months ended 31 Dec 2023LSE:AGYAllergy Therapeutics Plc
27/03/202408h00RNS Regulatory NewsAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
12/03/202415h06Alliance NewsAlliance NewsAllergy Therapeutics starts dosing patients in peanut allergy trialLSE:AGYAllergy Therapeutics Plc
12/03/202409h59RNS Regulatory NewsAllergy Therapeutics PLC VLP Peanut PROTECT Trial UpdateLSE:AGYAllergy Therapeutics Plc
11/03/202408h00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Shaun Furlong to Board of DirectorsLSE:AGYAllergy Therapeutics Plc
08/03/202414h49RNS Regulatory NewsAllergy Therapeutics PLC Result of AGMLSE:AGYAllergy Therapeutics Plc
14/02/202411h22Alliance NewsAlliance NewsAllergy Therapeutics forecasts revenue drop but trials going wellLSE:AGYAllergy Therapeutics Plc
14/02/202408h00RNS Regulatory NewsAllergy Therapeutics PLC Half-Year Trading Update 2024LSE:AGYAllergy Therapeutics Plc
09/02/202416h07RNS Regulatory NewsAllergy Therapeutics PLC Notice of 2023 Annual General MeetingLSE:AGYAllergy Therapeutics Plc
30/01/202411h38Alliance NewsAlliance NewsAllergy Therapeutics resumes trading on AIM; annual revenue plungesLSE:AGYAllergy Therapeutics Plc
30/01/202408h30RNS Regulatory NewsAIM Restoration - Allergy Therapeutics plcLSE:AGYAllergy Therapeutics Plc
30/01/202408h00RNS Regulatory NewsAllergy Therapeutics PLC Publication of Annual Report and Accounts 2023LSE:AGYAllergy Therapeutics Plc
04/01/202413h29UK RegulatoryAllergy Therapeutics PLC Total Voting RightsLSE:AGYAllergy Therapeutics Plc
02/01/202408h30UK RegulatoryAIM Suspension - Allergy Therapeutics plcLSE:AGYAllergy Therapeutics Plc
27/12/202315h17Alliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics amends facility, plans warrant issueLSE:AGYAllergy Therapeutics Plc
27/12/202313h01UK RegulatoryAllergy Therapeutics PLC Amendment to existing Facility AgreementLSE:AGYAllergy Therapeutics Plc
15/12/202322h09Alliance NewsAlliance NewsEARNINGS AND TRADING: Redx full year revenue tumbles; loss widensLSE:AGYAllergy Therapeutics Plc
15/12/202313h48UK RegulatoryAllergy Therapeutics PLC Annual Report and Accounts DelayedLSE:AGYAllergy Therapeutics Plc
13/12/202317h54UK RegulatoryAllergy Therapeutics PLC PDMR dealing and Total Voting RightsLSE:AGYAllergy Therapeutics Plc
13/12/202311h11Alliance NewsAlliance NewsAllergy Therapeutics shares jump as hails grass allergy jab dataLSE:AGYAllergy Therapeutics Plc
13/12/202308h00UK RegulatoryAllergy Therapeutics PLC G306 Phase III trial meets key endpointsLSE:AGYAllergy Therapeutics Plc
11/12/202311h40Alliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics stock falls on lower sales outlookLSE:AGYAllergy Therapeutics Plc
28/11/202316h03UK RegulatoryAllergy Therapeutics PLC Holding(s) in CompanyLSE:AGYAllergy Therapeutics Plc
14/11/202312h56Alliance NewsAlliance NewsAllergy Therapeutics says allergy therapy trial meets primary endpointLSE:AGYAllergy Therapeutics Plc
14/11/202308h00UK RegulatoryAllergy Therapeutics PLC G306 Grass Phase III trial meets primary endpointLSE:AGYAllergy Therapeutics Plc
10/11/202315h39UK RegulatoryPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)LSE:AGYAllergy Therapeutics Plc
 Showing the most relevant articles for your search:LSE:AGY

Dernières Valeurs Consultées

BIT
P1YPN2
NLBNPIT1YPN2 20240522 2
COIN
SLNDUSD
Solend
EU
DBRAV
Departement Bouches du R...
ASX
EQN
Equinox Resources
BIT
P1W9W0
NLBNPIT1W9W0 20991231 24...
USOTC
IGEN
iGen Networks (PK)
BIT
S29675
Societe Generale Effekten
NASDAQ
PKW
Invesco BuyBack Achiever...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés